SCHEMBL6274777

SCHEMBL6274777

O=C(O)C1CC(COc2cccc(Cl)c2)CN1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.45
KDM4E B2RXH2 4/20 0.43
AGTR2 P50052 1/20 0.42
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
FKBP1A P62942 1/20 0.41
HRH3 Q9Y5N1 7/20 0.41
WDR5 P61964 1/20 0.40
S1PR1 P21453 1/20 0.40
S1PR5 Q9H228 1/20 0.40
SCN9A Q15858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3178615 0.86 HDAC8 (0.43) GRM2KDM4EAGTR2ALDH1A1HRH3
SCHEMBL3178603 0.77 HDAC8 (0.43) GRM2ALDH1A1HRH3SCN9A
SCHEMBL13481738 0.73 STS (0.42) GRM2ALDH1A1HRH3SCN9A
SCHEMBL3163185 0.73 FFAR1 (0.55) KDM4EALDH1A1TP53TSHRHRH3
SCHEMBL3181096 0.73 RXRA (0.43) GRM2KDM4ERXRARXRBRXRG
SCHEMBL13481643 0.73 RXRA (0.43) GRM2KDM4ERXRARXRBRXRG
SCHEMBL5332291 0.73 GRM2 (0.48) GRM2KDM4ERXRARXRBRXRG
SCHEMBL1815343 0.71 FFAR1 (0.42) GRM2KDM4EAGTR2
SCHEMBL1815689 0.71 FFAR1 (0.42) GRM2KDM4EAGTR2
SCHEMBL23163612 0.71 HRH3 (0.47) GRM2KDM4EALDH1A1TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558246-A1 PROLINE DERIVATIVES HAVING AFFINITY FOR THE CALCIUM CHANNEL ALPHA-2-DELTA SUBUNIT Pfizer Limited (GB) 2005-08-03 EP disclosed
WO-2004039367-A1 PROLINE DERIVATIVES HAVING AFFINITY FOR THE CALCIUM CHANNEL ALPHA-2-DELTA SUBUNIT PFIZER LIMITED (GN) 2004-05-13 WO disclosed